Two Sigma Advisers’s Johnson & Johnson JNJ Stock Holding History

Two Sigma Advisers’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-350,509	Closed	-$72.5M	–	1097
2025 Q4	$72.5M	Sell	350,509 -1,995,734	-85%	-$395M	0.14%	152
2025 Q3	$435M	Buy	2,346,243 +1,927,200	+460%	+$330M	0.87%	22
2025 Q2	$64M	Sell	419,043 -99,100	-19%	-$15.2M	0.13%	159
2025 Q1	$85.9M	Buy	518,143 +328,800	+174%	+$51.4M	0.19%	109
2024 Q4	$27.4M	Buy	189,343 +61,493	+48%	+$9.53M	0.06%	250
2024 Q3	$20.7M	Sell	127,850 -928,259	-88%	-$148M	0.05%	314
2024 Q2	$154M	Buy	1,056,109 +307,600	+41%	+$45.7M	0.34%	64
2024 Q1	$118M	Sell	748,509 -1,331,500	-64%	-$212M	0.27%	81
2023 Q4	$326M	Buy	2,080,009 +1,915,200	+1,162%	+$294M	0.76%	20
2023 Q3	$25.7M	Sell	164,809 -843,191	-84%	-$139M	0.07%	251
2023 Q2	$167M	Sell	1,008,000 -1,803,200	-64%	-$291M	0.42%	62
2023 Q1	$436M	Sell	2,811,200 -200,100	-7%	-$32.3M	1.12%	7
2022 Q4	$532M	Sell	3,011,300 -106,400	-3%	-$18.4M	1.49%	3
2022 Q3	$509M	Buy	3,117,700 +959,400	+44%	+$162M	1.47%	2
2022 Q2	$383M	Sell	2,158,300 -203,500	-9%	-$36.3M	1.09%	7
2022 Q1	$419M	Sell	2,361,800 -825,100	-26%	-$140M	1.11%	9
2021 Q4	$545M	Sell	3,186,900 -82,100	-3%	-$13.4M	1.37%	2
2021 Q3	$528M	Buy	3,269,000 +433,400	+15%	+$73.9M	1.37%	3
2021 Q2	$467M	Buy	2,835,600 +145,100	+5%	+$24M	1.23%	3
2021 Q1	$442M	Buy	2,690,500 +2,471,000	+1,126%	+$400M	1.21%	6
2020 Q4	$34.5M	Sell	219,500 -102,148	-32%	-$15.1M	0.09%	232
2020 Q3	$47.9M	Sell	321,648 -550,117	-63%	-$81.4M	0.14%	153
2020 Q2	$123M	Sell	871,765 -328,500	-27%	-$47.9M	0.36%	55
2020 Q1	$157M	Sell	1,200,265 -2,764,400	-70%	-$392M	0.6%	23
2019 Q4	$578M	Sell	3,964,665 -506,700	-11%	-$68.7M	1.34%	2
2019 Q3	$579M	Buy	4,471,365 +512,800	+13%	+$67.6M	1.42%	2
2019 Q2	$551M	Buy	3,958,565 +2,195,200	+124%	+$304M	1.37%	2
2019 Q1	$247M	Sell	1,763,365 -758,100	-30%	-$102M	0.62%	24
2018 Q4	$325M	Buy	2,521,465 +445,000	+21%	+$62.1M	0.89%	8
2018 Q3	$287M	Sell	2,076,465 -972,800	-32%	-$129M	0.7%	14
2018 Q2	$370M	Buy	3,049,265 +2,947,200	+2,888%	+$368M	1%	2
2018 Q1	$13.1M	Buy	+102,065	New	+$13.8M	0.04%	501
2017 Q4	–	Sell	-240,232	Closed	-$31.2M	–	2314
2017 Q3	$31.2M	Sell	240,232 -807,820	-77%	-$107M	0.09%	268
2017 Q2	$139M	Buy	1,048,052 +287,787	+38%	+$36.7M	0.46%	44
2017 Q1	$94.7M	Buy	760,265 +89,091	+13%	+$10.6M	0.31%	76
2016 Q4	$77.3M	Buy	671,174 +322,525	+93%	+$37.3M	0.3%	85
2016 Q3	$41.2M	Buy	348,649 +196,227	+129%	+$23.8M	0.18%	136
2016 Q2	$18.5M	Sell	152,422 -36,000	-19%	-$4.09M	0.09%	242
2016 Q1	$20.4M	Buy	188,422 +150,634	+399%	+$15.6M	0.11%	208
2015 Q4	$3.88M	Sell	37,788 -629,566	-94%	-$63.3M	0.02%	523
2015 Q3	$62.3M	Buy	667,354 +310,434	+87%	+$30M	0.39%	66
2015 Q2	$34.8M	Buy	356,920 +2,846	+0.8%	+$285K	0.26%	99
2015 Q1	$35.6M	Buy	354,074 +300,523	+561%	+$30.6M	0.26%	104
2014 Q4	$5.6M	Sell	53,551 -199,223	-79%	-$21M	0.04%	454
2014 Q3	$26.9M	Buy	252,774 +215,033	+570%	+$22.3M	0.2%	117
2014 Q2	$3.95M	Sell	37,741 -73,233	-66%	-$7.4M	0.03%	546
2014 Q1	$10.9M	Sell	110,974 -197,600	-64%	-$18.3M	0.1%	221
2013 Q4	$28.3M	Sell	308,574 -875,300	-74%	-$80.7M	0.27%	75
2013 Q3	$103M	Buy	+1,183,874	New	+$106M	1.22%	4

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Advisers's JNJ Position: Q1 2026 in Review

Two Sigma Advisers sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 350,509 shares — an estimated $72.5M sold.

Two Sigma Advisers first reported a position in JNJ in Q3 2013 and held it in 49 quarters. The position peaked at $579M in Q3 2019. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Two Sigma Advisers reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 350,509 Johnson & Johnson shares in Q1 2026, an estimated $72.5M.
Two Sigma Advisers first reported a position in Johnson & Johnson in Q3 2013 and held it in 49 quarters.
Two Sigma Advisers's Johnson & Johnson position peaked at $579M in Q3 2019.
4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.